The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

This adran has no associated Memorandwm Esboniadol

133.  In regulation 166 (amendment of regulation 205 (obligations on holders in relation to public announcements))—U.K.

(a)in paragraph (2) for “for “bodies listed” to the end substitute “after “bodies listed in paragraph (3)” insert “ where the product is subject to a UKMA(NI), UKMA(UK), THR(NI), THR(UK) or Article 126a authorisation, or the licensing authority where the product is subject to a UKMA(GB) or THR(GB), ””;

(b)omit paragraph (3).

Commencement Information

I1Sch. 2 para. 133 in force at 31.12.2020 immediately before IP completion day, see reg. 1